Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Eliem Therapeutics, Inc. (ELYM)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.2 | 0.0 | | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | 0.0% | -43.0% | 0.0% | | 716.7% | |
ROIC (including intangibles) | 0.0% | -51.6% | 0.0% | -29.1% | 435.0% | -1043.2% |
ROE | 0.0% | -35.1% | 0.0% | -21.3% | 42.5% | -22.8% |
ROA | 0.0% | -33.4% | 0.0% | -20.6% | 37.2% | -21.9% |
|
Cash Conversion Cycle |
Days sales outstanding | | 0.0 | | 0.0 | | 0.0 |
Days payables outstanding | | 6.1 | | 14.4 | | 93.8 |
Cash conversion cycle | | -6.1 | | -14.4 | | -93.8 |
|